- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04758715
Diet and Microbiome Longitudinal Monitoring With Food Intervention
August 4, 2023 updated by: University of Nebraska Lincoln
The main goal of this project is to identify the microbiome components change in abundance in response to food ingested including provided foods.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68588
- University of Nebraska - Lincoln
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- willing to sign consent and have samples collected,
- able to read and speak English,
- participants must be willing to use an electronic food diary and consume study provided foods,
- only individuals able to provide a US address will be included.
Exclusion Criteria:
- Subjects not able to sign consent on their own accord (ie requiring a Legally Authorized Representative [LAR]),
- Current parenteral nutrition,
- Received cancer treatment within past 6 months prior to signing consent,
- Taken antibiotic treatment within the past 1 month prior to signing consent,
- Received oral x-ray contrast within the past 1 month prior to signing consent,
- Received any type of gastrointestinal bowel preparation in the past 1 month prior to signing consent,
- History of organ transplant,
- Shellfish allergy,
- Insect allergy,
- Cacti allergy,
- Carmine allergy,
- Dragon fruit (pitaya) allergy,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Food provided
Food provided from a commercial meal service provider for a week
|
Meals from a commercial meal service provider provide for a week to participant
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Microbiota variation
Time Frame: Up to 2 weeks
|
Ecological statistics will be used to analyze the longitudinal microbiome composition modification
|
Up to 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jacques Izard, PhD, Univeristy of Nebraska-Lincoln
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 2, 2021
Primary Completion (Estimated)
February 28, 2030
Study Completion (Estimated)
February 28, 2030
Study Registration Dates
First Submitted
February 8, 2021
First Submitted That Met QC Criteria
February 15, 2021
First Posted (Actual)
February 17, 2021
Study Record Updates
Last Update Posted (Actual)
August 7, 2023
Last Update Submitted That Met QC Criteria
August 4, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 20117
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Tract
-
Weill Medical College of Cornell UniversityUnknownEndoscopic Suturing Within the Gastrointestinal TractUnited States
-
Seoul National University HospitalRecruitingSubmucosal Tumor of Gastrointestinal TractKorea, Republic of
-
Methodist Health SystemCompletedEndoscopic Suturing | GI Tract Disorders | Gastrointestinal DisordersUnited States
-
TereosCEN BiotechCompleted
-
United States Army Research Institute of Environmental...Completed
-
National Cheng-Kung University HospitalNational Cheng Kung University; National Research Program for Biopharmaceuticals... and other collaboratorsCompletedSubmucosal Tumor of Gastrointestinal TractTaiwan
-
Zhejiang Cancer HospitalRecruiting
-
InnoPharmax Inc.TerminatedGastrointestinal Cancer | Biliary Tract CancerTaiwan
-
Istituto Clinico HumanitasNot yet recruitingDisease of Gastrointestinal Tract
-
Showa UniversityCompletedColonoscopy | Lower Gastrointestinal TractJapan
Clinical Trials on Food provided from a commercial meal service provider for a week
-
Montefiore Medical CenterBeyond MeatNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterTerminatedFibrillation | Post-Operative Cancer Patients Experiencing AtrialUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline; University of WashingtonCompletedProstate Cancer | Castration-resistant, MetastaticUnited States